← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE AND PRILOCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-04-08

Drug application

FDA Application #

ANDA213923

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE AND PRILOCAINE

Generic name

LIDOCAINE AND PRILOCAINE

Active ingredients

LIDOCAINE; PRILOCAINE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2022-04-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown